Guided Therapeutics Inc. (OTCMKTS:GTHP) Shares Shorted: Short Interest Up 63.4% in October

Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) was the target of a significant increase in short interest in October. As of October 30th, there was short interest totaling 2,817 shares, an increase of 63.4% from the October 15th total of 1,724 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 95,128 shares, the short-interest ratio is presently 0.0 days.

Guided Therapeutics Price Performance

GTHP stock opened at $0.11 on Tuesday. Guided Therapeutics has a 52-week low of $0.10 and a 52-week high of $0.54. The company’s 50 day simple moving average is $0.18 and its 200-day simple moving average is $0.24. The firm has a market capitalization of $10.80 million, a P/E ratio of -2.75 and a beta of 0.78.

Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last posted its quarterly earnings data on Monday, November 16th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.09 million for the quarter.

Guided Therapeutics Company Profile

(Get Free Report)

Guided Therapeutics is a medical technology company focused on developing tools for the detection of cervical disease. Its principal product is the LuViva Advanced Cervical Scan, a non-invasive device designed to assess cervical tissue for signs associated with precancerous changes and cancer. LuViva uses optical technologies to examine tissue and provide information that can support cervical disease evaluation. The company’s work centers on offering an alternative to diagnostic approaches that rely on collecting and analyzing tissue samples.

Further Reading

Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.